Page last updated: 2024-08-26

mci 9038 and Bright Disease

mci 9038 has been researched along with Bright Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ito, M; Suzuki, Y; Yamada, H	1

Other Studies

1 other study(ies) available for mci 9038 and Bright Disease

Article	Year
[Antinephritic effect of MD-805 [(2R, 4R) -4-methyl-[N2-(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl) -L-arginyl] -2-piperidine-carboxylic acid monohydrate], a new antithrombin agent, on crescentic-type anti-GMB nephritis in rats]. Nihon Jinzo Gakkai shi, 1984, Volume: 26, Issue:4 Topics: Animals; Arginine; Basement Membrane; Blood Urea Nitrogen; Glomerulonephritis; Heparin; Kidney Glomerulus; Male; Pipecolic Acids; Rats; Rats, Inbred Strains; Sulfonamides; Thrombin; Urokinase-Type Plasminogen Activator	1984

Article

Year

[Antinephritic effect of MD-805 [(2R, 4R) -4-methyl-[N2-(3-methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl) -L-arginyl] -2-piperidine-carboxylic acid monohydrate], a new antithrombin agent, on crescentic-type anti-GMB nephritis in rats].

Nihon Jinzo Gakkai shi, 1984, Volume: 26, Issue:4

Topics: Animals; Arginine; Basement Membrane; Blood Urea Nitrogen; Glomerulonephritis; Heparin; Kidney Glomerulus; Male; Pipecolic Acids; Rats; Rats, Inbred Strains; Sulfonamides; Thrombin; Urokinase-Type Plasminogen Activator

1984